Your institution may have access to this item. Find your institution then sign in to continue.
Title
Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.
Authors
Monsees, Genevieve M; Malone, Kathleen E; Tang, Mei-Tzu C; Newcomb, Polly A; Li, Christopher I
Abstract
A growing body of evidence suggests that nitrogenous bisphosphonates may reduce the risk of developing a first breast cancer and may prevent metastases among breast cancer survivors. However, their impact on risk of second primary contralateral breast cancer is uncertain.
Publication
Journal of the National Cancer Institute, 2011, Vol 103, Issue 23, p1752